Indications and uses
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
shake well before using use only with enclosed dosing cup adults and children 12 years of age and over take 10 mL every 12 hours; do not take more than 20 mL in 24 hours children 2 to under 12 years of age take 5 mL every 12 hours; do not take more than 10 mL in 24 hours children under 2 years of age ask a doctor adults 65 years of age and older ask a doctor consumers with kidney disease ask a doctor Note: mL = mi...
each 5 mL contains: phosphorus 15 mg and sodium 18 mg safety sealed: do not use if carton is opened or seal under cap opening is broken or missing store between 20° to 25°C (68° to 77°F)
Active ingredient (in each 5 mL)
Fexofenadine Hydrochloride USP 30 mg
Antihistamine
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
Do not use if you have ever had an allergic reaction to this product or any of its ingredients.
kidney disease. Your doctor should determine if you need a different dose.
an allergic reaction to this product occurs. Seek medical help right away.
If pregnant or breast-feeding, ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
| adults and children 12 years of age and over | take 10 mL every 12 hours; do not take more than 20 mL in 24 hours |
| children 2 to under 12 years of age | take 5 mL every 12 hours; do not take more than 10 mL in 24 hours |
| children under 2 years of age | ask a doctor |
| adults 65 years of age and older | ask a doctor |
| consumers with kidney disease | ask a doctor |
Note: mL = milliliters
dibasic sodium phosphate anhydrous, edetate disodium, ethylparaben, methylparaben, monobasic sodium phosphate, poloxamer 407, propylene glycol, purified water, raspberry flavor (contains propylene glycol and triacetin), raspberry sweet flavor (contains propylene glycol), sucrose, titanium dioxide, xanthan gum, xylitol.
Questions or comments?
call 1-855-274-4122 (Monday – Friday 8:30 AM to 5:00 PM EST)
Distributed by:
AUROHEALTH LLC
279 Princeton-Hightstown Road
East Windsor, NJ 08520
Made in India
Code: AP/DRUGS/04/2016
AUROHEALTH
NDC 58602-427-20
Ages 2 Years & Older
NON-DROWSY
Children’s
Fexofenadine Hydrochloride
Oral Suspension
30 mg/5 mL
antihistamine
INDOOR / OUTDOOR ALLERGY RELIEF
Dosing Cup Included
Wash and let air dry
after each use
12 HR
Raspberry
FLAVOR
Alcohol & Dye FREE
8 fl. oz. (240 mL)
AUROHEALTH
NDC 58602-427-20
#Compare to the active Ingredient
in Children’s Allegra®Allergy
Ages 2 Years & Older
Children’s
Fexofenadine Hydrochloride
Oral Suspension
30 mg/5 mL
antihistamine
12 HR
NON-DROWSY
Liquid
INDOOR / OUTDOOR ALLERGY RELIEF
√ Sneezing
√ Runny Nose
√ Itchy, Watery Eyes
√ Itchy Nose or Throat
Use Only With
Enclosed Dosing Cup
Wash and let air dry after each use
Raspberry
FLAVOR
Alcohol & Dye FREE
8 fl. oz. (240 mL)
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 58602-427 | 58602-427-24, 58602-427-20 |
Every source-derived ingredient row is available through these pages.
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A213466-001 | FEXOFENADINE HYDROCHLORIDE | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | 8072bd15b7f6… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | 3f0d92c62455… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A213466-001 | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | 2023-05-23 | a50c72e98297… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FEXOFENADINE HYDROCHLORIDE | FEXOFENADINE HYDROCHLORIDE ORAL | Aurohealth LLC | fe864426-c0d6-492a-96be-cd44fd9ca054 | 2026-09-01 | Warnings | 58602-427-24 58602-427-20 58602-427 58602042720 58602042724 fe864426-c0d6-492a-96be-cd44fd9ca054 fe864426-c0d6-492a-96be-cd44fd9ca054 |
Adverse event summaries are temporarily unavailable. Other product information remains available.